AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NOVA EYE MEDICAL LTD

0.162

-0.003-1.82%

Volume:65.91K

Turnover:10.78K

Market Cap:46.14M

PE:-4.42

High:0.165

Open:0.165

Low:0.160

Close:0.165

52wk High:0.205

52wk Low:0.086

Shares:284.83M

Float Shares:240.54M

Volume Ratio:0.44

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.037

EPS(LYR):-0.037

ROE:-44.96%

ROA:-19.92%

PB:2.43

PE(LYR):-4.42

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

BRIEF-Nova Eye Medical Posts December Quarter Sales Of $6.1 Million

Nova Eye Medical - December Quarter Sales of US$6.1 Mln

THOMSON REUTERS

Nova Eye Medical Says Statistical Report Backs Efficacy, Safety of Eye Surgery Device; Shares Up 3%

MT Newswires Live

There's No Escaping Nova Eye Medical Limited's (ASX:EYE) Muted Revenues Despite A 28% Share Price Rise

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/EYE.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EYE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EYE.AU\",,,,,undefined,":{"symbol":"EYE.AU","market":"AU","secType":"STK","nameCN":"NOVA EYE MEDICAL LTD","latestPrice":0.162,"timestamp":1771214613783,"preClose":0.165,"halted":0,"volume":65910,"delay":0,"changeRate":-0.0181818181818182,"nameEN":"NOVA EYE MEDICAL LTD","floatShares":240542047,"shares":284833284,"eps":-0.036626,"marketStatus":"Trading","change":-0.003,"latestTime":"02-16 15:04:15 AEDT","open":0.165,"high":0.165,"low":0.16,"amount":10780,"amplitude":0.030303,"askPrice":0.165,"askSize":307746,"bidPrice":0.16,"bidSize":354738,"shortable":3,"etf":0,"ttmEps":-0.036626,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771218000000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.165,"openAndCloseTimeList":[[1771196400000,1771218000000]],"volumeRatio":0.440875,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EYE.AU\",,,,,undefined,":{"symbol":"EYE.AU","floatShares":240542047,"roa":"-19.92%","roe":"-44.96%","lyrEps":-0.036626,"volumeRatio":0.440875,"shares":284833284,"dividePrice":0,"high":0.165,"amplitude":0.030303,"preClose":0.165,"low":0.16,"week52Low":0.086,"pbRate":"2.43","psRate":"1.58","week52High":0.205,"institutionHeld":0,"latestPrice":0.162,"committee":0.070933,"eps":-0.036626,"divideRate":0,"volume":65910,"delay":0,"ttmEps":-0.036626,"open":0.165,"prevYearClose":0.132,"prevWeekClose":0.165,"prevMonthClose":0.185,"prevQuarterClose":0.132,"fiveDayClose":0.165,"twentyDayClose":0.16,"sixtyDayClose":0.13,"dividendGrowthYears":0,"dividendGrowthRate":-1,"fiveYearAvgDividendRate":1.3621794871794872},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EYE.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-01","symbol":"EYE.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1769900400000,"name":null,"time":"","dateTimestamp":1769864400000,"actualEps":null},{"date":"2025-10-27","symbol":"EYE.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761519600000,"name":null,"time":"","dateTimestamp":1761483600000,"actualEps":null},{"market":"AU","date":"2024-02-13","symbol":"EYE.AU","defaultRemindTime":1707778800000,"type":"split","dateTimestamp":1707742800000,"forFactor":973737,"toFactor":1000000,"ratio":0.973737},{"date":"2023-08-28","symbol":"EYE.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693180800000,"name":null,"time":"","dateTimestamp":1693144800000,"actualEps":null},{"date":"2023-02-27","symbol":"EYE.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1677452400000,"name":null,"time":"","dateTimestamp":1677416400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EYE.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-07-21","recordDate":"2020-07-22","paymentDate":"2020-07-29","value":0.135,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EYE.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607720460","title":"BRIEF-Nova Eye Medical Posts December Quarter Sales Of $6.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2607720460","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607720460?lang=en_us&edition=fundamental","pubTime":"2026-01-29 09:30","pubTimestamp":1769650252,"startTime":"0","endTime":"0","summary":"BRIEF-Nova Eye Medical Posts December Quarter Sales Of $6.1 MillionJan 29 (Reuters) - Nova Eye Medical Ltd EYE.AX:DECEMBER QUARTER SALES OF US$6.1 MILLIONFurther company coverage: EYE.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YT16G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYE.AU","BK7007"],"gpt_icon":0},{"id":"2607738723","title":"Nova Eye Medical - December Quarter Sales of US$6.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2607738723","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607738723?lang=en_us&edition=fundamental","pubTime":"2026-01-29 05:45","pubTimestamp":1769636700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT16G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EYE.AU","BK7007"],"gpt_icon":0},{"id":"2606272168","title":"Nova Eye Medical Says Statistical Report Backs Efficacy, Safety of Eye Surgery Device; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606272168","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606272168?lang=en_us&edition=fundamental","pubTime":"2026-01-27 12:57","pubTimestamp":1769489877,"startTime":"0","endTime":"0","summary":"Nova Eye Medical  said the success rate in intraocular pressure reduction in patients with baseline intraocular pressure greater than 18 millimeters of mercury  was 85% in its 2025 statistical report on progress of patients in the iTrack Global Data Registry, an independently managed database, according to a Tuesday Australian bourse filing.Over 400 eyes reached the 12-month follow-up point under the registry, the filing said. Patients experienced a mean 40% reduction in medication burden across the group. There were six reported adverse events.The outcomes were considered clinically meaningful, per the filing, compared with other minimally invasive glaucoma surgery procedures.Nova Eye Medical's shares rose nearly 3% in recent trading on Tuesday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","EYE.AU"],"gpt_icon":0},{"id":"2604616582","title":"There's No Escaping Nova Eye Medical Limited's (ASX:EYE) Muted Revenues Despite A 28% Share Price Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2604616582","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604616582?lang=en_us&edition=fundamental","pubTime":"2026-01-20 06:28","pubTimestamp":1768861702,"startTime":"0","endTime":"0","summary":"Nova Eye Medical Limited ( ASX:EYE ) shareholders would be excited to see that the share price has had a great month...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-eye/nova-eye-medical-shares/news/theres-no-escaping-nova-eye-medical-limiteds-asxeye-muted-re","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-eye/nova-eye-medical-shares/news/theres-no-escaping-nova-eye-medical-limiteds-asxeye-muted-re","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EYE.AU","ELXMF","EYE"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/EYE.AU\",params:#limit:6,delay:true,,,undefined,":[]}}